Valuation check: TRUFF's profit margin is -213.37%, below the sector sector average of 12.13%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for TRUFF is -213.37% as of June 2026. That compares with -77.82% in the prior-year period — down 174.2% year over year. That is below the sector sector average of 12.13%. Investors often review this figure alongside Rhelion Life Sciences's historical trend and sector peers before judging valuation or financial health.
Over the past year, TRUFF's profit margin moved from -77.82% to -213.37% — a 174.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Rhelion Life Sciences's valuation or profitability profile.
Against its sector companies, TRUFF currently prints -213.37% for profit margin, while the sector average sits near 12.13%. That is roughly 1859.5% below the sector mean. Large gaps often invite a closer look at Rhelion Life Sciences's growth, margins, and balance sheet.
Profit Margin shows how effectively Rhelion Life Sciences converts resources into returns. At -213.37%, TRUFF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -77.82% in the prior-year period — down 174.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TRUFF's profit margin (-213.37%), review year-over-year change from -77.82%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.